NCT03863691View on ClinicalTrials.gov

Influence of Dopaminergic Blockade on Stress Responses, Motivation and Emotional Reactivity in Humans.

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

July 15, 2020

Study Completion Date

July 15, 2020

Conditions
Healthy Participants
Interventions
DRUG

Amisulpride 300 MG

A single dose of 300 mg amisulpride that looks identical to placebo control capsules.

DRUG

Placebo oral capsule

A placebo capsule with no inert pharmacological effect. Looks identical to the amisulpride capsules.

Trial Locations (1)

35037

Clinical Psychology and Psychotherapy, Gutenbergstr. 18, Marburg

All Listed Sponsors
collaborator

University of Hamburg-Eppendorf

OTHER

lead

Philipps University Marburg

OTHER

NCT03863691 - Influence of Dopaminergic Blockade on Stress Responses, Motivation and Emotional Reactivity in Humans. | Biotech Hunter | Biotech Hunter